Binding Database

The following articles (labelled with PubMed ID or TBD) are for your review

PMID

Data

Article Title

Organization

Recent Progress in Histone Demethylase Inhibitors.

University of Oxford

Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).

Hangzhou Normal University

First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53.

University of Oxford

Discovery of a new class of JMJD6 inhibitors and structure-activity relationship study.

Nankai University

Discovery of a potent and selective inhibitor of histone lysine demethylase KDM4D.

Nankai University

Identification of potent, selective KDM5 inhibitors.

Constellation Pharmaceuticals

Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models.

Celgene Quanticel Research

From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.

Genentech

Discovery of pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives as a new class of histone lysine demethylase 4D (KDM4D) inhibitors.

Sichuan University